News
more news »
How an AI solution can design new tuberculosis drug regimens A new method could replace trial and error drug development
November 21, 2019
With a shortage of new tuberculosis drugs in the pipeline, a software tool from the University of Michigan can predict how current drugs—including unlikely candidates—can be combined in new ways to create more effective treatments. “This could replace our traditional trial-and-error system for drug development that is comparatively slow and expensive,” said Sriram Chandrasekaran, a U-M […]
Read more »Debating Bioethics
November 4, 2019
Bioengineers tend talk a lot about how new technologies work. BME Lecturer Barry Belmont also wants to discuss their implications, and he isn’t the only one. “It’s one thing to learn the mechanics of gene therapy, for example, like how CRISPR works; it’s another to talk about some of the potential uses and the ethics […]
Read more »Implantable cancer traps could provide earlier diagnosis and help monitor treatment Synthetic scaffolding could detect multiple types of cancers before they start to spread.| Medium Read
October 30, 2019
Invasive procedures to biopsy tissue from cancer-tainted organs could be replaced by simply taking samples from a tiny “decoy” implanted just beneath the skin, University of Michigan researchers have demonstrated in mice. These devices have a knack for attracting cancer cells traveling through the body. In fact, they can even pick up signs that cancer […]
Read more »
